Blepharitis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Blepharitis is one of the most common [[ocular]] disorders encountered in clinical practice. | *Blepharitis is one of the most common [[ocular]] disorders encountered in clinical practice. | ||
Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and [[meibomian gland]] dysfunction (MGD).<ref name="pmid19277245">{{cite journal| author=Macsai MS| title=The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). | journal=Trans Am Ophthalmol Soc | year= 2008 | volume= 106 | issue= | pages= 336-56 | pmid=19277245 | doi= | pmc=2646454 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19277245 }} </ref> | *Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and [[meibomian gland]] dysfunction (MGD).<ref name="pmid19277245">{{cite journal| author=Macsai MS| title=The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). | journal=Trans Am Ophthalmol Soc | year= 2008 | volume= 106 | issue= | pages= 336-56 | pmid=19277245 | doi= | pmc=2646454 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19277245 }} </ref> | ||
===Age=== | ===Age=== | ||
Blepharitis can affect all age groups. | *Blepharitis can affect all age groups | ||
The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. | |||
The incidence of chronic blepharitis increase with age: the median age at diagnosis is 50 years. | |||
[Disease name] commonly affects individuals younger than/older than [number of years] years of age. | |||
*The incidence of chronic blepharitis increase with age: the median age at diagnosis is 50 years. | |||
*Staphylococcal blepharitis commonly affects younger population (avarage 42 years old).<ref name="pmid6743618">{{cite journal| author=Dougherty JM, McCulley JP| title=Comparative bacteriology of chronic blepharitis. | journal=Br J Ophthalmol | year= 1984 | volume= 68 | issue= 8 | pages= 524-8 | pmid=6743618 | doi= | pmc=1040405 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6743618 }} </ref> | |||
===Gender=== | ===Gender=== | ||
Female are more commonly affected with staphylococcal blepharitis than males.<ref name=Blepharitis> American Academy of Ophthalmology/ eyewiki (2016) http://eyewiki.aao.org/EyeWiki%3AGeneral_disclaimer| Accessed on July 14, 2016 </ref> | |||
===Race=== | ===Race=== | ||
There is no racial predilection to blepharitis. | There is no racial predilection to the blepharitis. | ||
===Developed Countries=== | ===Developed Countries=== | ||
In developed countries/United States, blepharitis affects more than 25 million people. In a survey [[ophthalmologists]] and optometrists report that blepharitis is commonly seen in clinical practice | was estimated to range from 3.300 to 30,000 per 100,000 individuals with | ||
In developed countries/United States, blepharitis affects more than 25 million people. In a survey [[ophthalmologists]] and optometrists report that blepharitis is commonly seen in clinical practice. The incidence of blepharitis was estimated to range from 37.000 to 47,000 per 100,000 patients.<ref name="pmid19383269">{{cite journal| author=Lemp MA, Nichols KK| title=Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. | journal=Ocul Surf | year= 2009 | volume= 7 | issue= 2 Suppl | pages= S1-S14 | pmid=19383269 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19383269 }} </ref> | |||
==References== | ==References== | ||
Revision as of 20:38, 24 July 2016
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis epidemiology and demographics On the Web | |
|
American Roentgen Ray Society Images of Blepharitis epidemiology and demographics | |
|
Risk calculators and risk factors for Blepharitis epidemiology and demographics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Blepharitis is one of the most common ocular disorders encountered in clinical practice. Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and meibomian gland dysfunction (MGD).[1]
Epidemiology and Demographics
- Blepharitis is one of the most common ocular disorders encountered in clinical practice.
- Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and meibomian gland dysfunction (MGD).[1]
Age
- Blepharitis can affect all age groups
The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. The incidence of chronic blepharitis increase with age: the median age at diagnosis is 50 years. [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- The incidence of chronic blepharitis increase with age: the median age at diagnosis is 50 years.
- Staphylococcal blepharitis commonly affects younger population (avarage 42 years old).[2]
Gender
Female are more commonly affected with staphylococcal blepharitis than males.[3]
Race
There is no racial predilection to the blepharitis.
Developed Countries
was estimated to range from 3.300 to 30,000 per 100,000 individuals with
In developed countries/United States, blepharitis affects more than 25 million people. In a survey ophthalmologists and optometrists report that blepharitis is commonly seen in clinical practice. The incidence of blepharitis was estimated to range from 37.000 to 47,000 per 100,000 patients.[4]
References
- ↑ 1.0 1.1 Macsai MS (2008). "The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)". Trans Am Ophthalmol Soc. 106: 336–56. PMC 2646454. PMID 19277245.
- ↑ Dougherty JM, McCulley JP (1984). "Comparative bacteriology of chronic blepharitis". Br J Ophthalmol. 68 (8): 524–8. PMC 1040405. PMID 6743618.
- ↑ American Academy of Ophthalmology/ eyewiki (2016) http://eyewiki.aao.org/EyeWiki%3AGeneral_disclaimer%7C Accessed on July 14, 2016
- ↑ Lemp MA, Nichols KK (2009). "Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment". Ocul Surf. 7 (2 Suppl): S1–S14. PMID 19383269.